Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Genoptix completes $74.9mm IPO

Executive Summary

Genoptix Inc. (also known as Genoptix Medical Laboratory; performs genetic testing services for cancer diagnostics) netted $74.9mm through its initial public offering of 4.73mm common shares (including the overallotment) at $17 each, higher than the company's anticipated range of $14-16. Selling stockholders also sold about 1mm shares.
Deal Industry
  • In Vitro Diagnostics
  • Laboratory Testing Services
  • Pharmaceuticals
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies